Literature DB >> 10450246

Relations between exposure to arsenic, skin lesions, and glucosuria.

M Rahman1, M Tondel, I A Chowdhury, O Axelson.   

Abstract

OBJECTIVES: Exposure to arsenic causes keratosis, hyperpigmentation, and hypopigmentation and seemingly also diabetes mellitus, at least in subjects with skin lesions. Here we evaluate the relations of arsenical skin lesions and glucosuria as a proxy for diabetes mellitus.
METHODS: Through existing measurements of arsenic in drinking water in Bangladesh, wells with and without arsenic contamination were identified. Based on a questionnaire, 1595 subjects > or = 30 years of age were interviewed; 1481 had a history of drinking water contaminated with arsenic whereas 114 had not. Time weighted mean arsenic concentrations and mg-years/l of exposure to arsenic were estimated based on the history of consumption of well water and current arsenic concentrations. Urine samples from the study subjects were tested by means of a glucometric strip. People with positive tests were considered to be cases of glucosuria.
RESULTS: A total of 430 (29%) of the exposed people were found to have skin lesions. Corresponding to drinking water with < 0.5, 0.5-1.0, and > 1.0 mg/l of arsenic, and with the 114 unexposed subjects as the reference, the prevalence ratios for glucosuria, as adjusted for age and sex, were 0.8, 1.4, and 1.4 for those without skin lesions, and 1.1, 2.2, and 2.6 for those with skin lesions. Taking exposure as < 1.0, 1.0-5.0, > 5.0-10.0 and > 10.0 mg-years/l of exposure to arsenic the prevalence ratios, similarly adjusted, were 0.4, 0.9, 1.2, and 1.7 for those without and 0.8, 1.7, 2.1, and 2.9 for those with skin lesions. All series of risk estimates were significant for trend, (p < 0.01).
CONCLUSIONS: The results suggest that skin lesions and diabetes mellitus, as here indicated by glucosuria, are largely independent effects of exposure to arsenic although glucosuria had some tendency to be associated with skin lesions. Importantly, however, glucosuria (diabetes mellitus) may occur independently of skin lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450246      PMCID: PMC1757723          DOI: 10.1136/oem.56.4.277

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  18 in total

1.  Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity.

Authors:  L Boquist; S Boquist; I Ericsson
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

2.  Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning.

Authors:  R Zaldívar
Journal:  Beitr Pathol       Date:  1974-04

3.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan.

Authors:  W P Tseng; H M Chu; S W How; J M Fong; C S Lin; S Yeh
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

5.  A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska.

Authors:  J M Harrington; J P Middaugh; D L Morse; J Housworth
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

6.  Chronic renal insufficiency from cortical necrosis induced by arsenic poisoning.

Authors:  R E Gerhardt; J B Hudson; R N Rao; R E Sobel
Journal:  Arch Intern Med       Date:  1978-08

7.  [Studies on As2O3-induced hyperglycemia (author's transl)].

Authors:  I Kawaguchi
Journal:  Nihon Yakurigaku Zasshi       Date:  1981-09

8.  Diabetes mellitus associated with arsenic exposure in Bangladesh.

Authors:  M Rahman; M Tondel; S A Ahmad; O Axelson
Journal:  Am J Epidemiol       Date:  1998-07-15       Impact factor: 4.897

9.  Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic.

Authors:  W P Tseng
Journal:  Environ Health Perspect       Date:  1977-08       Impact factor: 9.031

10.  Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant.

Authors:  J M Borgoño; P Vicent; H Venturino; A Infante
Journal:  Environ Health Perspect       Date:  1977-08       Impact factor: 9.031

View more
  20 in total

1.  Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh.

Authors:  Wen-Chi Pan; Wei Jie Seow; Molly L Kile; Elaine B Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Quan Lu; David C Christiani
Journal:  Am J Epidemiol       Date:  2013-09-18       Impact factor: 4.897

2.  Arsenic and fasting blood glucose in the context of other drinking water chemicals: a cross-sectional study in Bangladesh.

Authors:  Shadassa Ourshalimian; Abu Mohd Naser; Mahbubur Rahman; Solaiman Doza; Jennifer Stowell; K M Venkat Narayan; Mohammad Shamsudduha; Matthew O Gribble
Journal:  Environ Res       Date:  2018-12-21       Impact factor: 6.498

3.  Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes.

Authors:  David S Paul; Araceli Hernández-Zavala; Felecia S Walton; Blakely M Adair; Jirí Dedina; Tomás Matousek; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-30       Impact factor: 4.219

4.  Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh.

Authors:  Sudip Kumar Paul; Md Shofikul Islam; M M Hasibuzzaman; Faruk Hossain; Adiba Anjum; Zahangir Alam Saud; Md Mominul Haque; Papia Sultana; Azizul Haque; Klara Biljana Andric; Aminur Rahman; Md Rezaul Karim; Abu Eabrahim Siddique; Yeasir Karim; Mizanur Rahman; Hideki Miyataka; Lian Xin; Seiichiro Himeno; Khaled Hossain
Journal:  Sci Total Environ       Date:  2019-03-04       Impact factor: 7.963

5.  Burden of skin lesions of arsenicosis at higher exposure through groundwater of taluka Gambat district Khairpur, Pakistan: a cross-sectional survey.

Authors:  Zafar Fatmi; Imran Naeem Abbasi; Mubashir Ahmed; Ambreen Kazi; Fujio Kayama
Journal:  Environ Geochem Health       Date:  2012-10-31       Impact factor: 4.609

6.  Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.

Authors:  Yang Sun; Jingbo Pi; Xueqian Wang; Erik J Tokar; Jie Liu; Michael P Waalkes
Journal:  Toxicology       Date:  2009-06-12       Impact factor: 4.221

Review 7.  Chronic exposure of arsenic via drinking water and its adverse health impacts on humans.

Authors:  Mohammad Mahmudur Rahman; Jack C Ng; Ravi Naidu
Journal:  Environ Geochem Health       Date:  2009-02-04       Impact factor: 4.609

8.  Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh.

Authors:  Rafiqul Islam; Ismail Khan; Sheikh Nazmul Hassan; Mark McEvoy; Catherine D'Este; John Attia; Roseanne Peel; Munira Sultana; Shahnaz Akter; Abul Hasnat Milton
Journal:  Environ Health       Date:  2012-06-07       Impact factor: 5.984

Review 9.  Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review.

Authors:  Elizabeth A Maull; Habibul Ahsan; Joshua Edwards; Matthew P Longnecker; Ana Navas-Acien; Jingbo Pi; Ellen K Silbergeld; Miroslav Styblo; Chin-Hsiao Tseng; Kristina A Thayer; Dana Loomis
Journal:  Environ Health Perspect       Date:  2012-08-10       Impact factor: 9.031

10.  Arsenic exposure and calpain-10 polymorphisms impair the function of pancreatic beta-cells in humans: a pilot study of risk factors for T2DM.

Authors:  Andrea Díaz-Villaseñor; Laura Cruz; Arturo Cebrián; Raúl U Hernández-Ramírez; Marcia Hiriart; Gonzálo García-Vargas; Susana Bassol; Monserrat Sordo; A Jay Gandolfi; Walter T Klimecki; Lizbeth López-Carillo; Mariano E Cebrián; Patricia Ostrosky-Wegman
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.